The interpretation of secondary blood markers can get hazardous in case of a discontinuous rhEPO treatment.
Robinson
Neil
N
Laboratoire Suisse d'Analyse du Dopage, Institut Universitaire de Médecine Légale, Rue du Bugnon 21, 1005 Lausanne, Switzerland. neil.robinson@inst.hospvd.ch
Saugy
Martial
M
Buclin
Thierry
T
Gremion
Gérald
G
Mangin
Patrice
P
D015415:Biomarkers / Q000097:blood; D004300:Doping in Sports; D004921:Erythropoietin / Q000008:administration & dosage* / Q000097:blood; D006400:Hematocrit; D006801:Humans; D007501:Iron / Q000008:administration & dosage / Q000097:blood; D010507:Periodicity; D011994:Recombinant Proteins; D015813:Substance Abuse Detection / Q000379:methods*
D015415:Biomarkers; D011994:Recombinant Proteins; D004921:Erythropoietin; D007501:Iron